Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;11(6):e50.
doi: 10.1016/S2213-2600(23)00148-0.

ACT trials: long-term outcomes

John W Eikelboom  1 , Emilie Belley-Cote  2 , Richard P Whitlock  3 , Sanjit S Jolly  2 , Sean Wasserman  4 , Salim Yusuf  2 ; ACT Trials Steering Committee
Affiliations

ACT trials: long-term outcomes

John W Eikelboom et al. Lancet Respir Med. 2023 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

JWE reports grant or in-kind support from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, GlaxoSmithKline, Pfizer, Janssen, and Sanofi-Aventis and honoraria from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, Eli Lilly, GlaxoSmithKline, Merck, Pfizer, Janssen, Sanofi-Aventis, and Servier. EB-C reports grant support from Bayer, Roche, and Bristol Myers Squibb-Pfizer. RPW reports grant support from Bayer, Roche, and BMS-Pfizer; grant support and honorarium from Boehringer Ingelheim; and consultancy fees from Atricure and Phasebio. SSJ reports grant support from Boston Scientific and honoraria from Medtronic and Penumbra. SW reports honoraria from Pfizer; and safety monitoring committee membership of an AIDS Clinical Trial Group. SY reports institutional grant support, honoraria, and travel costs for lectures from Bayer.

References

    1. Eikelboom JW, Jolly SS, Belley-Cote EP, et al. Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial. Lancet Respir Med. 2022;10:1169–1177. - PMC - PubMed
    1. Eikelboom JW, Jolly SS, Belley-Cote EP, et al. Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial. Lancet Respir Med. 2022;10:1160–1168. - PMC - PubMed
    1. Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28:583–590. - PMC - PubMed
    1. Wu N, Joyal-Desmarais K, Ribeiro PAB, et al. Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022. Lancet Respir Med. 2023;11:439–452. - PMC - PubMed